Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation

13가 폐렴구균 결합 백신 시행 6년 후 아동의 지역사회 획득성 세균성 폐렴 유출 및 흉막 농양의 원인 변화

Published on
Journal: Journal of the Pediatric Infectious Diseases Society
[저자] Fouad Madhi, Corinne Levy, Laurence Morin, Philippe Minodier, François Dubos, Ferielle Zenkhri, Marie Aliette Dommergues, Ellia Mezgueldi, Karine Levieux, Pneumonia Study Group, Stéphane Béchet, Emmanuelle Varon, Robert Cohen, GPIP (Pediatric Infectious Disease Group)
[Category] 폐렴구균 감염증,
Pubmed URL    DOI URL    
[Source] pubmed

We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009-2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection decreased during the study from 79.1% in 2009 to 36.4% in 2017 (P < .001). Group A streptococcus is now the leading cause of documented empyema (45.5%).

All Keywords
【저자키워드】 children, bacterial pneumonia, pleural effusion, Empyema, PCV13,